We document a strong and negative relationship between changes in cohort size and marriage rates for both women and men. We provide the most convincing evidence on this relationship by using variation in cohort size due to differences across states in sale bans on oral contraceptives. This empirical pattern is puzzling if interpreted using insights derived from the previous literature and stand...

Published retrospective studies of the relationship between the use of oral contraceptives and disease have assumed that women are able to recall their oral contraceptive histories with reasonable accuracy. The validity of this assumption has been investigated by comparing oral contraceptive histories obtained from 75 women attending family planning clinics with the information contained in the...

With their numbers on the rise, school-based health centers are an important source of counseling and medical care for low-income and uninsured youth. Controversy over family planning services has had a significant impact, however, and many centers remain limited in their ability to meet the needs of sexually active teens by dispensing contraceptives to them on-site. At the same time, a number ...

Currently, Contraceptive agents play a key role in family planning in India. Hormonal contraception is the marketed most common birth control option in women. An estimated 100 million women throughout the world use hormonal contraceptives for prevention of pregnancy. This article briefly describes the recent advances in hormonal contraceptive strategies that may minimize side effects while opti...

The authors used data from a population-based, case-control study of breast cancer conducted among women residing in King County, Washington State, who were 50-64 years of age in 1988-1990, to examine the relation of oral contraceptive use to the risk of breast cancer. There were no clear differences between cases and controls with respect to the total duration of oral contraceptive use, time s...

OBJECTIVE To investigate compliance, satisfaction, and preference in women using a transdermal contraceptive patch. METHODS Women (18-46 years) from eight European countries used contraceptive patches (norelgestromin 6 mg, ethinylestradiol 600 μg) for six, 4-week treatment cycles. Compliance, satisfaction, and preference were assessed after 3 and 6 cycles and study completion using self-repor...